0001415889-24-005087.txt : 20240223 0001415889-24-005087.hdr.sgml : 20240223 20240223172648 ACCESSION NUMBER: 0001415889-24-005087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240206 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farokhzad Omid CENTRAL INDEX KEY: 0001586852 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39747 FILM NUMBER: 24672747 MAIL ADDRESS: STREET 1: C/O SEER, INC. STREET 2: 3800 BRIDGE PARKWAY, SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seer, Inc. CENTRAL INDEX KEY: 0001726445 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 821153150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3800 BRIDGE PARKWAY, SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-453-0000 MAIL ADDRESS: STREET 1: 3800 BRIDGE PARKWAY, SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Seer Biosciences, Inc. DATE OF NAME CHANGE: 20171226 4 1 form4-02232024_100239.xml X0508 4 2024-02-06 0001726445 Seer, Inc. SEER 0001586852 Farokhzad Omid C/O SEER, INC. 3800 BRIDGE PARKWAY, SUITE 102 REDWOOD CITY CA 94065 true true false false CEO AND CHAIR 0 Class A Common Stock 2024-02-06 4 A 0 529634 0 A 1489142 D Employee Stock Option (right to buy) 1.77 2024-02-06 4 A 0 1032901 0 A 2034-02-06 Class A Common Stock 1032901 1032901 D The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on February 15, 2025. The option is subject to vesting requirements based upon achievement of specified performance-based criteria (the "Stock Price Hurdle") which requires that the Issuer achieve a stock price equal to or greater than 300% of the option exercise price during the period beginning on the grant date and ending on February 6, 2031 (the "Performance Period"). If the Stock Price Hurdle is achieved within the Performance Period, then one-fourth of the shares subject to the option vest on the date that achievement of the Stock Price Hurdle is certified and the remaining shares vest annually thereafter in three equal installments. /s/ David Horn, by power of attorney 2024-02-23